ABVX
Price
$7.65
Change
+$0.25 (+3.38%)
Updated
Jun 30 closing price
Capitalization
465.51M
41 days until earnings call
SYRE
Price
$14.97
Change
-$0.25 (-1.64%)
Updated
Jun 30 closing price
Capitalization
902.89M
30 days until earnings call
Interact to see
Advertisement

ABVX vs SYRE

Header iconABVX vs SYRE Comparison
Open Charts ABVX vs SYREBanner chart's image
Abivax SA
Price$7.65
Change+$0.25 (+3.38%)
Volume$487.21K
Capitalization465.51M
Spyre Therapeutics
Price$14.97
Change-$0.25 (-1.64%)
Volume$437.91K
Capitalization902.89M
ABVX vs SYRE Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. SYRE commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Buy and SYRE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (ABVX: $7.65 vs. SYRE: $14.97)
Brand notoriety: ABVX and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 224% vs. SYRE: 80%
Market capitalization -- ABVX: $465.51M vs. SYRE: $902.89M
ABVX [@Biotechnology] is valued at $465.51M. SYRE’s [@Biotechnology] market capitalization is $902.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVX is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 4 TA indicator(s) are bullish while SYRE’s TA Score has 4 bullish TA indicator(s).

  • ABVX’s TA Score: 4 bullish, 6 bearish.
  • SYRE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ABVX and SYRE are a bad buy in the short-term.

Price Growth

ABVX (@Biotechnology) experienced а +25.20% price change this week, while SYRE (@Biotechnology) price change was +1.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

ABVX is expected to report earnings on Aug 11, 2025.

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($903M) has a higher market cap than ABVX($466M). ABVX YTD gains are higher at: 4.508 vs. SYRE (-35.696). ABVX has higher annual earnings (EBITDA): -170.04M vs. SYRE (-214.36M). SYRE has more cash in the bank: 565M vs. ABVX (104M). SYRE has less debt than ABVX: SYRE (0) vs ABVX (92.6M). ABVX (0) and SYRE (0) have equivalent revenues.
ABVXSYREABVX / SYRE
Capitalization466M903M52%
EBITDA-170.04M-214.36M79%
Gain YTD4.508-35.696-13%
P/E RatioN/A1.72-
Revenue00-
Total Cash104M565M18%
Total Debt92.6M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXSYRE
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDVRX14.14N/A
N/A
Hartford International Equity R3
BMGCX27.84N/A
N/A
BlackRock Mid-Cap Growth Equity Inv C
JMVAX15.62N/A
N/A
Janus Henderson Mid Cap Value I
PWTYX52.15N/A
N/A
UBS US Allocation P
PBSRX13.90N/A
N/A
Polen US Small Company Growth Investor

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with SYRE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+3.38%
SYRE - ABVX
38%
Loosely correlated
-1.64%
CGON - ABVX
38%
Loosely correlated
+0.19%
XENE - ABVX
38%
Loosely correlated
-3.40%
MLTX - ABVX
35%
Loosely correlated
-0.67%
DYN - ABVX
35%
Loosely correlated
-0.52%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with CGON. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-1.64%
CGON - SYRE
58%
Loosely correlated
+0.19%
BEAM - SYRE
57%
Loosely correlated
+1.25%
IMNM - SYRE
56%
Loosely correlated
+6.04%
XNCR - SYRE
55%
Loosely correlated
-3.44%
APGE - SYRE
53%
Loosely correlated
+0.12%
More